Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis

Journal of Neuroimmunology

Volumn 119, Issue 2, 2001, Pages 358-364

  Sharief, M K ^a   Semra, Y K ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Cerebrospinal fluid; Intrathecal; Multiple sclerosis; Survivin

Indexed keywords

FAS ANTIGEN; MITOGENIC AGENT; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROTECTION; CELL STIMULATION; CELL SURVIVAL; CELL VIABILITY; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

APOPTOSIS; CELL SURVIVAL; CEREBROSPINAL FLUID; CHROMOSOMAL PROTEINS, NON-HISTONE; HUMANS; LYMPHOCYTE ACTIVATION; MICROTUBULE-ASSOCIATED PROTEINS; MITOGENS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEOPLASM PROTEINS; T-LYMPHOCYTES;

EID: 0035479123     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00389-7     Document Type: Article

References (42)

1. Survivin apoptosis. An interloper between cell death and cell proliferation in cancer
2. A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma
3. Multiple sclerosis - Emerging concepts of disease pathogenesis
4. Serum sAPO-1/Fas levels in multiple sclerosis
5. Expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin
6. Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients
7. Defective T cell Fas function in patients with multiple sclerosis
8. Evidence that survivin inhibit caspase-3 activity
9. Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions
10. Resistance to glucocorticoid-induced apoptosis in PLP peptide-specific T cell clones from patients with progressive MS
11. IAP family proteins. Suppressors of apoptosis
12. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
13. CD95-mediated apoptosis and DNA fragmentation in MS
14. Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy
15. Escaping cell death. Survival proteins in cancer
16. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation
17. Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis
18. Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine
19. An exegesis of IAPs. Salvation and surprises from BIR motifs
20. Fas/APO-1/CD95 in health and autoimmune disease. Thymic and peripheral aspects
21. The Bcl-2 family and cell death regulation
22. Control of apoptosis during angiogenesis by survivin expression in endothelial cells
23. Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance
24. BIRinging chromosomes through cell division-and survivin' the experience
25. Survivin' cell-separation anxiety
26. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
27. Serum levels of apoptosis-related molecules in patients with multiple sclerosis and human T-lymphotropic virus Type I-associated myelopathy
28. T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy
29. Fas(t) track to apoptosis in MS-TNF receptors may suppress or potentiate CNS demyelination
30. Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis
31. Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis
32. Increased cellular expression of the caspase inhibitor FLIP in intrathecal lymphocytes from patients with MS
33. Disturbed expression of the anti-apoptosis gene, Survivin, and EPR-1 in hematological malignancies
34. Inhibition of Fas death signals by FLIPs
35. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes
36. Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis
37. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells
38. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli
39. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis
40. Bcl-2 expressing T lymphocytes in multiple sclerosis lesions
41. Immune (dys)regulation in multiple sclerosis. Role of the CD95-CD95 ligand system
42. Serum CD95 of relapsing remitting multiple sclerosis patients protects from CD95-mediated apoptosis